MK-0431-402

· Merck Sharp & Dohme LLC

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MK-0431-402, covering 2013-08-26 to 2013-08-26. Get the full timeline:

Most recent: Clinical Trial Update: Evaluation of Low Blood Sugar Events in Participants With Diabetes (MK-0431-402)